contracts (917.54) (576.04) 341.50 59.28 Gross profit 101.75 75.25 26.50 35.21 Other income 2.69 4.25 (1.56) (36.63) Profit before expense 104.44 79.50 24.94 31.37 Administrative expensed (58.54) (50.42) 8.12
contracts (917.54) (576.04) 341.50 59.28 Gross profit 101.75 75.25 26.50 35.21 Other income 2.69 4.25 (1.56) (36.63) Profit before expense 104.44 79.50 24.94 31.37 Administrative expensed (58.54) (50.42) 8.12
801 106 13% Cost of sales and services -789 -621 168 27% -682 -608 74 12% Gross Profit 248 235 13 5% 225 193 32 16% Other Income 5 0 5 1,701% 14 7 7 117% Selling expense -81 -70 11 16% -71 -61 10 17
change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9
* -58.0% Consol. Net Profit 255.1 159.0 268.6 +60.4% 559.7 -54.4% [ Remark * Excludes foreign exchange rate effects. ** Excludes foreign exchange rate effects and change in retirement benefit provisions
) - (870.5) N.A.(
acquisition of FKRMM's shares is a transac been a customer of NDR for more than 10 years, and in Malaysia with 4 distribution warehouse FKRMM,NDR’s profit will immediately share and retain the existing
business operations, having main proportional sale is export. 1.2 Summary of operating results. For the year ending 31 December 2017, the Company had net profit amounting 42.91 million Baht, profit increased
subsidiaries by having the main substance is as follows. (Unit: Thousand Baht) Revenues Gross Profit Selling Admin Net profit 2017 837,308 293,207 80,159 93,260 -236,013 2018 929,354 325,527 88,001 79,800
2017 ended December 31, 2017 of the Company and its subsidiaries, as shown below : (Unit : Million Baht) 2017 2016 Change Revenue 837 849 -1.4% Gross profit margin 293 342 -16.7% Selling Expenses 80 96